These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 8822794)

  • 1. Apoptosis mediated by the Fas system.
    Nagata S
    Prog Mol Subcell Biol; 1996; 16():87-103. PubMed ID: 8822794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constitutive activation of the Fas ligand gene in mouse lymphoproliferative disorders.
    Watanabe D; Suda T; Hashimoto H; Nagata S
    EMBO J; 1995 Jan; 14(1):12-8. PubMed ID: 7530197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand.
    Takahashi T; Tanaka M; Brannan CI; Jenkins NA; Copeland NG; Suda T; Nagata S
    Cell; 1994 Mar; 76(6):969-76. PubMed ID: 7511063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why do defects in the Fas-Fas ligand system cause autoimmunity?
    Suda T; Nagata S
    J Allergy Clin Immunol; 1997 Dec; 100(6 Pt 2):S97-101. PubMed ID: 9440553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell receptor ligation triggers novel nonapoptotic cell death pathways that are Fas-independent or Fas-dependent.
    Davidson WF; Haudenschild C; Kwon J; Williams MS
    J Immunol; 2002 Dec; 169(11):6218-30. PubMed ID: 12444127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A death factor--the other side of the coin.
    Nagata S
    Behring Inst Mitt; 1996 Oct; (97):1-11. PubMed ID: 8950463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular interactions in the lpr and gld models of systemic autoimmunity.
    Sobel ES
    Adv Dent Res; 1996 Apr; 10(1):76-80. PubMed ID: 8934931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human autoimmune lymphoproliferative syndrome, a defect in the apoptosis-inducing Fas receptor: a lesson from the mouse model.
    Nagata S
    J Hum Genet; 1998; 43(1):2-8. PubMed ID: 9609991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fas and Fas ligand: lpr and gld mutations.
    Nagata S; Suda T
    Immunol Today; 1995 Jan; 16(1):39-43. PubMed ID: 7533498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role for the Fas/Fas ligand apoptotic pathway in regulating myeloid progenitor cell kinetics.
    Alenzi FQ; Marley SB; Lewis JL; Chandrashekran A; Warrens AN; Goldman JM; Gordon MY
    Exp Hematol; 2002 Dec; 30(12):1428-35. PubMed ID: 12482505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immune regulatory function of lymphoproliferative double negative T cells in vitro and in vivo.
    Ford MS; Young KJ; Zhang Z; Ohashi PS; Zhang L
    J Exp Med; 2002 Jul; 196(2):261-7. PubMed ID: 12119351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant expression and dysfunction of Fas antigen in MRL/MpJ-lpr/lpr murine ovary.
    Xu JP; Li X; Mori E; Guo MW; Mori T
    Zygote; 1998 Nov; 6(4):359-67. PubMed ID: 9921647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression in transgenic mice of dominant interfering Fas mutations: a model for human autoimmune lymphoproliferative syndrome.
    Choi Y; Ramnath VR; Eaton AS; Chen A; Simon-Stoos KL; Kleiner DE; Erikson J; Puck JM
    Clin Immunol; 1999 Oct; 93(1):34-45. PubMed ID: 10497009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fas- or FasL-deficient mice display an increased sensitivity to nitrobenzene-induced testicular germ cell apoptosis.
    Richburg JH; Nañez A
    Toxicol Lett; 2003 Mar; 139(1):1-10. PubMed ID: 12595153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fas/Fas ligand pathway, apoptosis, and clonal anergy involved in systemic acetylcholine receptor T cell epitope tolerance.
    Deng C; Goluszko E; Christadoss P
    J Immunol; 2001 Mar; 166(5):3458-67. PubMed ID: 11207304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Essential roles of the Fas ligand in the development of hepatitis.
    Kondo T; Suda T; Fukuyama H; Adachi M; Nagata S
    Nat Med; 1997 Apr; 3(4):409-13. PubMed ID: 9095174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively.
    Hashimoto W; Osaki T; Okamura H; Robbins PD; Kurimoto M; Nagata S; Lotze MT; Tahara H
    J Immunol; 1999 Jul; 163(2):583-9. PubMed ID: 10395644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations.
    Siegel RM; Frederiksen JK; Zacharias DA; Chan FK; Johnson M; Lynch D; Tsien RY; Lenardo MJ
    Science; 2000 Jun; 288(5475):2354-7. PubMed ID: 10875918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fas-mediated cytotoxicity is not required for rejection of murine nonvascularized heterotopic cardiac allografts.
    Djamali A; Odorico JS
    Transplantation; 1998 Dec; 66(12):1793-801. PubMed ID: 9884278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fas system-mediated apoptosis suppresses lymphopoiesis.
    Yasutomo K; Nagasawa H; Hisaeda H; Good RA; Kuroda Y; Himeno K
    J Immunol; 1996 Sep; 157(5):1981-6. PubMed ID: 8757318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.